Fig. 6 | Scientific Reports

Fig. 6

From: Development of a PANoptosis-related LncRNAs for prognosis predicting and immune infiltration characterization of gastric Cancer

Fig. 6

Immune infiltration status and drug sensitivity analysis in low-risk and high-risk groups of gastric cancer patients. (A) Tumor purity. (B) ESTIMATE score. (C) Stromal Score. (D) Immune phenotype score (IPS). (E) Proportions of 23 types of cells in low-risk and high-risk subgroups of patients. (F) Correlation between immune cell infiltration and prognostic genes. (G) Dasatinib. (H) Erlotinib. (I) Imatinib. (J) Paclitaxel. (K) Rapamycin. (L) Saracatinib. (M) Sorafenib. (N) Sunitinib.

Back to article page